| Income Statement |
| Operating Expenses | 47.86M |
|
| Research and Development Expense | 28.89M |
| Selling, General and Administrative Expense | 13.72M |
| Operating Income | -47.86M |
| Net Income | -46.99M |
| Net Income Common Stock | -46.99M |
| Net Income Common Stock (USD) | -34.05M |
| Consolidated Income | -46.99M |
| Earnings per Basic Share | -0.85 |
| Earnings per Basic Share (USD) | -0.62 |
| Earnings per Diluted Share | -0.85 |
| Earning Before Interest & Taxes (EBIT) | -46.99M |
| Earning Before Interest & Taxes (USD) | -34.05M |
| Weighted Average Shares | 34.80M |
| Weighted Average Shares Diluted | 34.80M |
| Balance Sheet |
| Cash and Equivalents | 157.26M |
| Cash and Equivalents (USD) | 113.96M |
| Trade and Non-Trade Receivables | 5.03M |
| Current Assets | 184.52M |
| Property, Plant & Equipment Net | 195.00K |
| Total Assets | 251.17M |
| Current Liabilities | 19.38M |
| Total Liabilities | 19.38M |
| Accumulated Retained Earnings (Deficit) | -389.53M |
| Accumulated Other Comprehensive Income | 630.00K |
| Shareholders Equity | 231.79M |
| Shareholders Equity (USD) | 167.96M |
| Assets Non-Current | 66.64M |
| Goodwill and Intangible Assets | 66.45M |
| Trade and Non-Trade Payables | 19.38M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 31.00K |
| Net Cash Flow from Financing | -169.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -37.87M |
| Capital Expenditure | -323.00K |
| Net Cash Flow from Investing | -323.00K |
| Net Cash Flow from Operations | -37.29M |
| Effect of Exchange Rate Changes on Cash | -87.00K |
| Share Based Compensation | 5.26M |